LARIMAR THERAPEUTICS, INC.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Aug 4, 2025
SCHEDULE 13D/A Jul 31, 2025
8-K Jul 31, 2025 8-K
424B5 Jul 31, 2025 424B5
8-K Jul 29, 2025 8-K
424B5 Jul 29, 2025 424B5
8-K Jun 23, 2025 8-K
8-K Jun 23, 2025 8-K
SCHEDULE 13G Jun 17, 2025
4 May 15, 2025
4 May 14, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 14, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 14, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 14, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 14, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
SCHEDULE 13G/A May 14, 2025
8-K May 13, 2025 8-K
SCHEDULE 13G/A May 13, 2025
8-K May 5, 2025 8-K
10-Q Apr 30, 2025 10-Q
8-K Apr 30, 2025 8-K
SCHEDULE 13G/A Apr 22, 2025
SCHEDULE 13G Apr 16, 2025
ARS Apr 11, 2025 ARS
DEF 14A Apr 11, 2025 DEF 14A
← Newer Page 3 of 28 · 693 filings Older →